Market Cap 1.26B
Revenue (ttm) 8.33M
Net Income (ttm) -89.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,072.03%
Debt to Equity Ratio 0.17
Volume 2,991,300
Avg Vol 3,027,814
Day's Range N/A - N/A
Shares Out 273.92M
Stochastic %K 43%
Beta 1.01
Analysts Strong Sell
Price Target $11.00

Company Profile

Taysha Gene Therapies, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of SLC13A5 deficiency; TSHA-113 for t...

Industry: Biotechnology
Sector: Healthcare
Phone: 214 612 0000
Address:
3000 Pegasus Park Drive, Suite 1430, Dallas, United States
Dark_Horse_Investments
Dark_Horse_Investments Feb. 9 at 8:46 PM
$TSHA Provided dosing is completed without hiccups ( no toxicity event ) two entertaining questions : 1) what could be the top end market cap in the event of a buyout transaction? 2) what is more compelling to us, share whom you consider as likely buyers ? Feel this is critical to achieve a meaningful market cap ($3 to $4 B cap)... Your thoughts. THX in advance
0 · Reply
UgoGreg
UgoGreg Feb. 8 at 3:16 PM
$TSHA https://youtu.be/b4CDDEB3OQo
1 · Reply
WoIfofWaIIst
WoIfofWaIIst Feb. 7 at 6:40 PM
0 · Reply
WoIfofWaIIst
WoIfofWaIIst Feb. 7 at 6:39 PM
$TSHA - and now it’s at the very top 😂
0 · Reply
WoIfofWaIIst
WoIfofWaIIst Feb. 7 at 5:39 PM
$TSHA - So how does this come 3rd in my watchlist? When no one talks on here
0 · Reply
stockmoe12
stockmoe12 Feb. 6 at 4:29 PM
$TSHA nice volume today …
0 · Reply
stockmoe12
stockmoe12 Feb. 6 at 3:11 PM
$TSHA peak revenue 2-3b so buyout could be 5-6b after ph3 results or 3-4b before ph3 data results .. lets see
0 · Reply
stockmoe12
stockmoe12 Feb. 6 at 3:05 PM
$TSHA buyout in few weeks/months
0 · Reply
stockmoe12
stockmoe12 Feb. 6 at 3:04 PM
$TSHA 13-F by FMR llc :https://ir.tayshagtx.com/node/10146/html
0 · Reply
WoIfofWaIIst
WoIfofWaIIst Feb. 6 at 2:30 PM
0 · Reply
Latest News on TSHA
Why Is Taysha Gene Therapies Stock Trading Higher On Thursday?

May 29, 2025, 1:06 PM EDT - 9 months ago

Why Is Taysha Gene Therapies Stock Trading Higher On Thursday?


Taysha Gene Therapies Is Showing Promise For Rett Syndrome

Jan 27, 2025, 7:53 PM EST - 1 year ago

Taysha Gene Therapies Is Showing Promise For Rett Syndrome


What's Going On With Taysha Gene Therapies Stock Tuesday?

Jun 18, 2024, 11:42 AM EDT - 1 year ago

What's Going On With Taysha Gene Therapies Stock Tuesday?


Taysha: Initial Rett Syndrome Data Leads To Other 2024 Catalysts

Mar 20, 2024, 12:30 PM EDT - 2 years ago

Taysha: Initial Rett Syndrome Data Leads To Other 2024 Catalysts


Dark_Horse_Investments
Dark_Horse_Investments Feb. 9 at 8:46 PM
$TSHA Provided dosing is completed without hiccups ( no toxicity event ) two entertaining questions : 1) what could be the top end market cap in the event of a buyout transaction? 2) what is more compelling to us, share whom you consider as likely buyers ? Feel this is critical to achieve a meaningful market cap ($3 to $4 B cap)... Your thoughts. THX in advance
0 · Reply
UgoGreg
UgoGreg Feb. 8 at 3:16 PM
$TSHA https://youtu.be/b4CDDEB3OQo
1 · Reply
WoIfofWaIIst
WoIfofWaIIst Feb. 7 at 6:40 PM
0 · Reply
WoIfofWaIIst
WoIfofWaIIst Feb. 7 at 6:39 PM
$TSHA - and now it’s at the very top 😂
0 · Reply
WoIfofWaIIst
WoIfofWaIIst Feb. 7 at 5:39 PM
$TSHA - So how does this come 3rd in my watchlist? When no one talks on here
0 · Reply
stockmoe12
stockmoe12 Feb. 6 at 4:29 PM
$TSHA nice volume today …
0 · Reply
stockmoe12
stockmoe12 Feb. 6 at 3:11 PM
$TSHA peak revenue 2-3b so buyout could be 5-6b after ph3 results or 3-4b before ph3 data results .. lets see
0 · Reply
stockmoe12
stockmoe12 Feb. 6 at 3:05 PM
$TSHA buyout in few weeks/months
0 · Reply
stockmoe12
stockmoe12 Feb. 6 at 3:04 PM
$TSHA 13-F by FMR llc :https://ir.tayshagtx.com/node/10146/html
0 · Reply
WoIfofWaIIst
WoIfofWaIIst Feb. 6 at 2:30 PM
0 · Reply
stockmoe12
stockmoe12 Feb. 6 at 1:41 PM
0 · Reply
GammaSage
GammaSage Feb. 4 at 2:13 PM
$TSHA is a clinical-stage gene therapy company focused on the central nervous system; its lead program for a rare disease is promising but carries high clinical risk.
0 · Reply
quickaspeter
quickaspeter Feb. 3 at 4:18 PM
$TSHA - Jefferies massively increased its position (up 4,105.3%) to 10,313,733 shares (~$23.8M), and institutional investors now own about 77.7% of the company. - SG Americas Securities LLC cut its stake in Taysha by 93.3% in Q3, selling 460,352 shares and leaving 32,949 shares valued at about $108,000. - Company insiders sold a total of 967,140 shares worth $4.51 million in the past 90 days — including CFO Kamran Alam (78,968 shares at $4.75) — leaving insiders with 3.78% ownership.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 3 at 3:24 PM
$TSHA RSI: 47.15, MACD: -0.1445 Vol: 0.24, MA20: 4.83, MA50: 5.05 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
1 · Reply
Quantumup
Quantumup Feb. 3 at 11:31 AM
Citizens reiterated $ACAD Market Outperform-$34 and said, Likely negative CHMP opinion on the trofinetide MAA for Rett syndrome slows expansion into the EU $TSHA $NGNE $AVXL Citizens added, Yesterday afternoon, Acadia announced a negative CHMP trend vote on its trofinetide MAA for Rett Syndrome after an oral explanation, and the company expects a negative CHMP opinion. The formal CHMP opinion is anticipated later in February, and management intends to seek a re-examination of the opinion should it be unfavorable. While this update is disappointing, exU.S. sales of trofinetide represent potential upside to our model and valuation.
0 · Reply
warren5677
warren5677 Feb. 2 at 10:48 PM
$TSHA Jefferies increased stake in TSHA by 4100%. Adds 10 million shares. https://www.marketbeat.com/instant-alerts/filing-taysha-gene-therapies-inc-tsha-shares-sold-by-sg-americas-securities-llc-2026-02-01/
0 · Reply
WoIfofWaIIst
WoIfofWaIIst Feb. 2 at 6:54 PM
$TSHA $IBRX $OPTT My picks this week ladies and gents GLTA
1 · Reply
WoIfofWaIIst
WoIfofWaIIst Feb. 2 at 6:54 PM
$TSHA - Wow this board is quite. Let’s wake this baby up
0 · Reply
Dark_Horse_Investments
Dark_Horse_Investments Jan. 30 at 12:52 AM
$TSHA Fellow ‘high conviction & deep due diligence’ TSHA longs… Been noodling on the following, as the co nears full dosing & eventually data maturation for BLA (biologics license application) submission, perhaps by Q4: a) in the camp that the most viable exit is an acquisition by big pharma or a specialty pharma; b) what ballpark market capitalization could TSHA achieve upon approval, and; c) ultimately who could be a potential acquirer & expected date for a transaction, Astellas (relinquished first rights to TSHA-102) (18 months)? Others & @ what price/market cap? Been pondering to whom this asset is the most attractive & best fit their strategic profile? It is not the traditional bp, eg MRK, PFE or Novo to name the usual suspects – it is somebody else! Furthermore, Sean Nolan, Suku Najandram & of course Paul Manning are experienced deal makers & thus expect they are sowing the field for the harvest. Kindly share your educated thoughts here for the benefit of all.
1 · Reply
Johnny_443
Johnny_443 Jan. 29 at 2:26 PM
$TSHA CEO Nolan just bought a new house.
1 · Reply
Aawilliam2003
Aawilliam2003 Jan. 28 at 4:41 PM
$TSHA vs $NGNE ??? Both look good, $NGNE way cheaper
3 · Reply
JoeNolff6
JoeNolff6 Jan. 28 at 3:08 PM
$TSHA what is happening?
1 · Reply